Dynavax (DVAX) Reports In-Line Q2 EPS

Dynavax (NASDAQ: DVAX) reported Q2 EPS of ($0.63), in-line with the analyst estimate of ($0.63). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.62 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance